Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Prolonged exposure to reduced levels of androgen accelerates prostate cancer progression in Nkx3.1; Pten mutant mice.

Banach-Petrosky W, Jessen WJ, Ouyang X, Gao H, Rao J, Quinn J, Aronow BJ, Abate-Shen C.

Cancer Res. 2007 Oct 1;67(19):9089-96.

2.

Full-length cDNA sequence and genomic organization of human NKX3A - alternative forms and regulation by both androgens and estrogens.

Korkmaz KS, Korkmaz CG, Ragnhildstveit E, Kizildag S, Pretlow TG, Saatcioglu F.

Gene. 2000 Dec 30;260(1-2):25-36.

PMID:
11137288
3.

A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer.

He WW, Sciavolino PJ, Wing J, Augustus M, Hudson P, Meissner PS, Curtis RT, Shell BK, Bostwick DG, Tindall DJ, Gelmann EP, Abate-Shen C, Carter KC.

Genomics. 1997 Jul 1;43(1):69-77.

PMID:
9226374
4.

Context-dependent hormone-refractory progression revealed through characterization of a novel murine prostate cancer cell line.

Watson PA, Ellwood-Yen K, King JC, Wongvipat J, Lebeau MM, Sawyers CL.

Cancer Res. 2005 Dec 15;65(24):11565-71.

5.

Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer.

Stanbrough M, Bubley GJ, Ross K, Golub TR, Rubin MA, Penning TM, Febbo PG, Balk SP.

Cancer Res. 2006 Mar 1;66(5):2815-25.

6.

Emergence of androgen independence at early stages of prostate cancer progression in Nkx3.1; Pten mice.

Gao H, Ouyang X, Banach-Petrosky WA, Shen MM, Abate-Shen C.

Cancer Res. 2006 Aug 15;66(16):7929-33.

7.

Loss-of-function of Nkx3.1 promotes increased oxidative damage in prostate carcinogenesis.

Ouyang X, DeWeese TL, Nelson WG, Abate-Shen C.

Cancer Res. 2005 Aug 1;65(15):6773-9.

8.

Expression profiling of the mouse prostate after castration and hormone replacement: implication of H-cadherin in prostate tumorigenesis.

Wang XD, Wang BE, Soriano R, Zha J, Zhang Z, Modrusan Z, Cunha GR, Gao WQ.

Differentiation. 2007 Mar;75(3):219-34. Epub 2006 Dec 11.

PMID:
17288544
9.

Nkx3.1 mutant mice recapitulate early stages of prostate carcinogenesis.

Kim MJ, Bhatia-Gaur R, Banach-Petrosky WA, Desai N, Wang Y, Hayward SW, Cunha GR, Cardiff RD, Shen MM, Abate-Shen C.

Cancer Res. 2002 Jun 1;62(11):2999-3004.

10.

Loss of Nkx3.1 expression in the transgenic adenocarcinoma of mouse prostate model.

Bethel CR, Bieberich CJ.

Prostate. 2007 Dec 1;67(16):1740-50.

PMID:
17929276
11.

Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells.

Wang P, Ma Q, Luo J, Liu B, Tan F, Zhang Z, Chen Z.

Cancer Invest. 2009 May;27(4):369-75. doi: 10.1080/07357900802232749.

PMID:
19266349
12.
13.

Isolation and androgen regulation of the human homeobox cDNA, NKX3.1.

Prescott JL, Blok L, Tindall DJ.

Prostate. 1998 Apr 1;35(1):71-80.

PMID:
9537602
14.

Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression.

Bowen C, Bubendorf L, Voeller HJ, Slack R, Willi N, Sauter G, Gasser TC, Koivisto P, Lack EE, Kononen J, Kallioniemi OP, Gelmann EP.

Cancer Res. 2000 Nov 1;60(21):6111-5.

15.

Relaxin becomes upregulated during prostate cancer progression to androgen independence and is negatively regulated by androgens.

Thompson VC, Morris TG, Cochrane DR, Cavanagh J, Wafa LA, Hamilton T, Wang S, Fazli L, Gleave ME, Nelson CC.

Prostate. 2006 Dec 1;66(16):1698-709.

PMID:
16998820
16.

Conditional loss of Nkx3.1 in adult mice induces prostatic intraepithelial neoplasia.

Abdulkadir SA, Magee JA, Peters TJ, Kaleem Z, Naughton CK, Humphrey PA, Milbrandt J.

Mol Cell Biol. 2002 Mar;22(5):1495-503.

17.

Inactivation of Apc in the mouse prostate causes prostate carcinoma.

Bruxvoort KJ, Charbonneau HM, Giambernardi TA, Goolsby JC, Qian CN, Zylstra CR, Robinson DR, Roy-Burman P, Shaw AK, Buckner-Berghuis BD, Sigler RE, Resau JH, Sullivan R, Bushman W, Williams BO.

Cancer Res. 2007 Mar 15;67(6):2490-6.

18.

Mechanisms of prostate tumorigenesis: roles for transcription factors Nkx3.1 and Egr1.

Abdulkadir SA.

Ann N Y Acad Sci. 2005 Nov;1059:33-40. Review.

PMID:
16382041
19.

Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer.

Locke JA, Guns ES, Lubik AA, Adomat HH, Hendy SC, Wood CA, Ettinger SL, Gleave ME, Nelson CC.

Cancer Res. 2008 Aug 1;68(15):6407-15. doi: 10.1158/0008-5472.CAN-07-5997.

20.

Functional analysis of NKX3.1 in LNCaP prostate cancer cells by RNA interference.

Possner M, Heuser M, Kaulfuss S, Scharf JG, Schulz W, Hermann-Ringert R, Thelen P.

Int J Oncol. 2008 Apr;32(4):877-84.

PMID:
18360715

Supplemental Content

Support Center